Zhang Ning, Qu Xuan, Zhou Haokang, Kang Lin
Department of Geriatrics, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, CHN.
Department of Internal Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, CHN.
Cureus. 2024 Jun 13;16(6):e62300. doi: 10.7759/cureus.62300. eCollection 2024 Jun.
Background The prevalence of obesity in combination with sarcopenia, the age-related loss of muscle mass and strength or physical function, is on the rise among adults aged 65 years and older. A significant portion of this demographic now falls under the classification of sarcopenic obesity, a high-risk geriatric syndrome predominantly seen in an aging population vulnerable to compounded complications from both sarcopenia and obesity. It is essential to promptly evaluate the impact of academic research in this field, taking into account factors such as geographical regions, authors, journals, and institutions. Furthermore, exploring current topics and identifying potential areas that could inspire future researchers to conduct additional studies is crucial for advancing overall health in this population. Methodology A search was conducted in the Web of Science Core Collection database to identify English language articles and reviews focusing on sarcopenic obesity in older adults, published between January 1, 2004, and December 31, 2023. Bibliometric analysis was performed using VOSviewer (v.1.6.18) and CiteSpace (v.6.1.R2). Results A total of 985 original English-language articles were collected, consisting of 783 articles and 202 reviews. The volume of research publications in this field has shown significant growth since 2012. The United States leads in contributions, with 239 articles (24.3% of the total) and the highest number of citations at 18,403, along with the highest total link strength. The University of Melbourne in Australia stands out with 25 published articles (2.5% of the total). University of Verona in Italy has the most citations at 9,405, and Monash University in Australia has the highest total link strength at 53. Among prolific authors, John A. Batsis from Duke University is the most productive with 24 articles (2.4% of the total). The journal "Nutrients" has the most articles on sarcopenic obesity in older adults, publishing 54 articles (5.5% of the total). Key topics in this area include sarcopenia, obesity, sarcopenic obesity, and elderly. Recent interventions focus on "nutrition" and "exercise" for sarcopenic obesity in older adults. Conclusions Research on sarcopenic obesity in older adults has seen significant growth on a global scale from 2004 to 2023, indicating a promising area for further study with potential benefits from current advancements. Although academic inquiries have shed light on various aspects of sarcopenic obesity in older adults, there remains a noticeable dearth of clinical research and evidence-based medicine on the effective management of this condition in elderly individuals. Future studies could focus on developing tailored interventions for older adults with sarcopenic obesity.
背景:肥胖与肌肉减少症(与年龄相关的肌肉量、力量或身体功能丧失)并存的情况在65岁及以上的成年人中呈上升趋势。这一人群中有很大一部分属于肌肉减少性肥胖的范畴,这是一种高危老年综合征,主要出现在易因肌肉减少症和肥胖症而出现复合并发症的老年人群中。必须及时评估该领域学术研究的影响,同时考虑地理区域、作者、期刊和机构等因素。此外,探索当前主题并确定可能激发未来研究人员开展更多研究的潜在领域,对于促进这一人群的整体健康至关重要。 方法:在科学网核心合集数据库中进行检索,以识别2004年1月1日至2023年12月31日期间发表的聚焦于老年人肌肉减少性肥胖的英文文章和综述。使用VOSviewer(v.1.6.18)和CiteSpace(v.6.1.R2)进行文献计量分析。 结果:共收集到985篇英文原创文章,其中包括783篇论文和202篇综述。自2012年以来,该领域的研究出版物数量显著增长。美国的贡献最大,有239篇文章(占总数的24.3%),被引次数最高,为18403次,总链接强度也最高。澳大利亚的墨尔本大学表现突出,发表了25篇文章(占总数的2.5%)。意大利的维罗纳大学被引次数最多,为9405次,澳大利亚的莫纳什大学总链接强度最高,为53。在多产作者中,杜克大学的约翰·A·巴齐斯产量最高,发表了24篇文章(占总数的2.4%)。《营养素》杂志发表的关于老年人肌肉减少性肥胖的文章最多,有54篇(占总数的5.5%)。该领域的关键主题包括肌肉减少症、肥胖症、肌肉减少性肥胖和老年人。近期的干预措施聚焦于老年人肌肉减少性肥胖的“营养”和“运动”。 结论:2004年至2023年期间,全球范围内关于老年人肌肉减少性肥胖的研究有显著增长,表明这是一个有前景的进一步研究领域,当前的进展可能带来益处。尽管学术研究揭示了老年人肌肉减少性肥胖的各个方面,但在有效管理老年人这种状况方面,临床研究和循证医学仍然明显不足。未来的研究可以专注于为患有肌肉减少性肥胖的老年人制定量身定制的干预措施。
Medicine (Baltimore). 2023-11-3
Cochrane Database Syst Rev. 2022-2-1
Medicine (Baltimore). 2024-9-20
Clin Oral Investig. 2025-1-16
Nat Rev Endocrinol. 2024-5
Hum Vaccin Immunother. 2022-11-30
Curr Probl Cardiol. 2023-8
Front Endocrinol (Lausanne). 2022
Arch Gerontol Geriatr. 2020-4-8
J Am Med Dir Assoc. 2020-3